A significant reduction of macrophages expressing inducible nitric oxide synthase in rat hepatic allografts pretreated with donor-specific blood

Transplantation

Volumn 65, Issue 6, 1998, Pages 776-785

  Ichiguchi, Osamu ^a   Yamaguchi, Yasuo ^a   Goto, Mataro ^a   Matsumura, Fujio ^a   Miyanari, Nobutomo ^a   Akizuki, Eiji ^a   Matsuda, Teishi ^a   Okabe, Kazutoshi ^a   Liang, Jian ^a   Ohshiro, Hajime ^a   Mori, Katsutaka ^a   Ogawa, Michio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MESSENGER RNA; MONOCLONAL ANTIBODY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LOCALIZATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; LIVER TRANSPLANTATION; MACROPHAGE FUNCTION; MALE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT;

ANIMALS; GENE EXPRESSION; GRAFT SURVIVAL; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; LIVER TRANSPLANTATION; MACROPHAGES; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RATS; RATS, INBRED ACI; RATS, INBRED LEW; RNA, MESSENGER; TH2 CELLS; TIME FACTORS; TISSUE DONORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032571356     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199803270-00003     Document Type: Article

References (70)

1. Langrehr JM, Hoffman RA, Lancaster JR, Simmons RL. Nitric oxide: a new endogenous immunomodulator. Transplantation 1993; 55: 1205.
2. Langrehr JM, Murase N, Markus PM, et al. Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest 1992; 90: 679.
3. Lancaster JR, Langrehr JM, Bergonia HA, Murase N, Simmons RL, Hoffman RA. EPR detection of heme and non-heme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem 1992; 267: 10994.
4. Langrehr JM, Hoffman RA, Billiar TR, Lee KK, Schraut WH, Simmons RL. Nitric oxide synthesis in the in vivo allograft response: a possible regulatory mechanism. Surgery 1991; 110: 335
5. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157: 87.
6. Rees DD, Cellek S, Palmer RM, Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun 1990; 173: 547.
7. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043.
8. Curran RD, Billiar TR, Stuehr DJ, Hoffman K, Simmons RL. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 1989; 170: 1769.
9. Billiar TR, Curran RD, Stuehr DJ, West MA, Bentz BG, Simmons RL. An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med 1989; 169: 1467.
10. Pfeilschifter J, Rob P, Mulsch A, Fandrey J, Vosbeck K, Busse R. Interleukin-1-β and tumor necrosis factor-a induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur J Biochem 1992; 203: 251.
11. Wood ML, Gottschalk R, Monaco AP. The effect of timing of multiple donor-specific or nonspecific blood transfusions on skin allograft survival in ALS-treated mice. Transplantation 1983; 36: 388.
12. Opelz G, Terasaki PI. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med 1978; 299: 799.
13. Yamaguchi Y, Harland RC, Wyble C, Mori K, Bollinger RR. Variable allograft responses after administration of donor splenocytes treated with mitomycin C in the rat. Transplantation 1989; 47: 360.
14. Yamaguchi Y, Kikuchi N, Miyanari N, et al. Technique for orthotopic reduced-size hepatic transplantation combined with ex vivo liver cut down in the rat. Dig Dis Sci 1996; 41: 1713.
15. National Institutes of Health. Guide for the care and use of laboratory animals. Public Health Service: NIH Publication No. 86-23. Bethesda, MD: National Institutes of Health, 1985.
16. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal Biochem 1982;126:131.
17. Matsuno K, Ezaki T, Kotani M. Splenic outer periarterial lymphoid sheath (PALS): an immunoproliferative microenvironment constituted by antigen-laden marginal metallophils and ED2-positive macrophage in the rat. Cell Tissue Res 1989; 257: 459.
18. Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2, and ED3. Immunology 1985; 54: 589.
19. Xie Q-W, Cho HJ, Calaycay J, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
21. Langrehr JM, White DA, Hoffman RA, Simmons RL. Macrophages produce nitric oxide at allograft sites. Ann Surg 1993; 218: 159.
22. Stein-Oakley AN, Jablonski P, Tzandis A, et al. Development of chronic injury and nature of interstitial infiltrate in a model of chronic renal allograft rejection. Transplantation 1993; 56: 1299.
23. Cattell V, Jansen A. Inducible nitric oxide synthase in inflammation. Histochem J 1995; 27: 777.
24. Paul LC, Grothman GT, Benediktsson H, Davidoff A, Rozing J. Macrophage subpopulations in normal and transplanted heart and kidney tissues in the rat. Transplantation 1992; 53: 157.
25. Hoffman RA, Langrehr JM, Dull KE, Simmons RL. Nitric oxide production by mouse sponge matrix allograft-infiltrating cells. Transplantation 1993; 55: 591.
26. Worrall NK, Lazenby WD, Misko TP, et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995; 181: 63.
27. Hart DN, Fabre JW. Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J Exp Med 1981; 154: 347.
28. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens: a novel pathway for initiation of rejection. J Exp Med 1990; 171: 307.
29. Demetris AJ, Qian S, Sun H, et al. Early events in liver allograft rejection: delineation of sites of simultanenous intragraft and recipient lymphoid tissue sensitization. Am J Pathol 1991; 138: 609.
30. Langrehr JM, Dull KE, Ochoa JB, et al. Evidence that nitric oxide production by in vivo allosensitized cells inhibits the development of allospecific CTL. Transplantation 1992; 53: 632.
31. Hoffman RA, Langrehr JM, Billiar TR, Curran RD, Simmons RL. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol 1990; 145: 2220.
32. Mills CD. Molecular basis of "suppressor" macrophages: arginine metabolism via the nitric oxide synthase pathway. J Immunol 1991; 146: 2719.
33. Gregory SH, Sagnimeni AJ, Wing EJ. Arginine analogues suppress antigen-specific and nonspecific T lymphocyte proliferation. Cell Immunol 1994; 153: 527.
34. Hoffmann MW, Wonigeit K, Steinhoff G, Herzbeck H, Flad HD, Pichlmayr R. Production of cytokines (TNF-alpha, IL-1-beta) and endothelial cell activation in human liver allograft rejection. Transplantation 1993; 55: 329.
35. Imanaga DK, Mills JM, Olthoff KM, et al. Anti-tumor necrosis factor antibody enhances allograft survival in rats. J Surg Res 1990; 48: 345.
36. Terasaki PI. The beneficial transfusion effect on kidney graft survival attributed to clonal deletion. Transplantation 1984; 37: 119.
37. Yamaguchi Y, Harland RC, Wyble C, Bollinger RR. The role of class I major histocompatibility complex antigens in prolonging the survial of hepatic allografts in the rat. Transplantation 1989; 47: 171.
38. Martin DR, Sheng-Tanner X, Miller RG. Rapid and long-term changes to host cytotoxic T lymphocyte precursors reactive to donor antigens caused by intravenous injection of histocompatible lymphocytes. Transplantation 1992; 54: 125.
39. Downey WE, Baldwin WM, Sanfilippo F. Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of anti-idiotypic antibodies and reduced alloantibody responses. Transplantation 1990; 49: 160.
40. Dallman MJ, Shiho O, Page TJ, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
41. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081.
42. Abramson SL, Gallin JI. IL-4 inhibits superoxide production by human mononuclear phagocytes. J Immunol 1990; 144: 625.
43. Martinez OM, Gibbons RS, Garovoy MR, Aronson FR. IL-4 inhibits IL-2 receptor expression and IL-2 dependent proliferation of human T cells. J Immunol 1990; 144: 2211.
44. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems: the differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
45. + T cells, Th2-like effector cells, in prolonging hepatic allografts in rats pretreated with a donor specific blood transfusion. Hepatology 1997; 25: 1008.
46. Joyce DA, Steer JH. IL-4, IL-10 and IFN-γ have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes. Cytokine 1996; 8: 49.
47. Suk K, Erickson KL. Differential regulation of tumor necrosis factor-alpha mRNA degradation in macrophages by interleukin-4 and interferon-y. Immunology 1996; 87: 551.
48. + T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J Immunol 1991; 147: 2713.
49. Mosmann TR. Regulation of immune responses by T cells with different cytokine secretion phenotypes: role of a new cytokine, cytokine synthesis inhibitory factor (IL-10). Int Arch All Appl Immunol 1991; 94: 110.
50. Lohoff M, Marsig E, Rollinghoff M. Murine IL-4 antagonizes the protective effects of IFN on virus-mediated lysis of murine L929 fibroblast cells. J Immunol 1990; 144: 960.
51. Trinchieri G, Scott P. The role of interleukin 12 in the immune response, disease and therapy. Immunol Today 1994; 15: 460.
52. Hendrzak JA, Brunda MJ. Interleukin-12: biologic activity, therapeutic utility, and role in disease. Lab Invest 1995; 72: 619.
53. Mathieson PW, Gillespie KM. Cloning of a partial cDNA of rat interleukin-12 (IL-12) and analysis of IL-12 expression in vivo. Scand J Immunol 1996; 44: 11.
54. Tsung K, Meko JB, Peplinski GR, Tsung YL, Morton JA. IL-12 induces T helper 1-directed antitumor response. J Immunol 1997; 158: 3359.
55. Bertagnolli MM, Lin B-Y, Young D, Hermann SH. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J Immunol 1992; 149: 3778.
56. Cesano A, Visonneau S, Clark SC, Santoli D. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. J Immunol 1993; 151: 2943.
57. Chen C, Nabavi N. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1994; 1: 147.
58. Car BD, Eng VM, Schnyder B, et al. Role of interferon-γ in interleukin 12-induced pathology in mice. Am J Pathol 1995; 147: 1693.
59. D'Andrea A, Rengaraju M, Valiane NM, et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992; 176: 1387.
60. Wu C-Y, Demeure C, Kiniwa M, Gately M, Delespesse G. IL-12 induces the production of IFN-γ by neonatal human CD4 T cells. J Immunol 1993; 151: 1938.
61. Huang FP, Feng GJ, Lindop G, Stott DI, Liew FY. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL:MP-lpr:lpr mice. J Exp Med 1996; 183: 1447.
62. Waldburger KE, Hastings RC, Schaub RG, Goldman SJ, Leonard JP. Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12: preferential expansion of interferon-γ-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms. Am J Pathol 1996; 148: 375.
63. Wynn TA, Reynolds A, James S, et al. IL-12 enhances vaccine- induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J Immunol 1996; 157: 4068.
64. Zidek Z, Lotzova E, Frankova D, Savary CA. Indirect stimulatory effects of murine interleukin-12 on in vitro production of nitric oxide by mouse peritoneal cells. J Interferon Cytokine Res 1996; 16: 389.
65. Leonard JP, Waldburger KE, Goldman SJ. Regulation of experimental autoimmune encephalomyelitis by interleukin-12. Ann NY Acad Sci 1996; 795: 216.
66. Wigginton JM, Kuhns DB, Back TC, Brunda MJ, Wiltrout RH, Cox GW. Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the antitumor activity of interleukin 12 and/or interleukin 2. Cancer Res 1996; 56: 1131.
67. + T lymphocytes. J Immunol 1995; 155: 111.
68. Vouldoukis I, Becherel PA, Riveros-Moreno V, et al. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol 1997; 27: 860.
69. Weiss G, Schwaighofer H, Herold M, et al. Nitric oxide formation as predictive parameter for acute graft-versus-host disease after human allogeneic bone marrow transplantation. Transplantation 1995; 60: 1239.
70. Groeneveld PH, Kwappenberg KM, Langermans JA, Nibbering PH, Curtis L. Relation between pro-and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis. Cytokine 1997; 9: 138.